cells. E-CEL Technology is potentially applicable to every tissue/organ in the body. Recently, we were awarded a $3.5M 'clinical track' grant from the California Institute of Regenerative Medicine (CIRM). The CIRM award fully pays for the road of our allogeneic Coif-the-shelf) E-CEL UVEC program reaching the clinic trial stage. E-CEL UVEC is